A zinc(II)-dipicolylamine coordination complex acts as a chemical trigger to release 5-ALA from stealth liposomes and allow uptake into neighboring mammalian cells for conversion into fluorescent PpIX.
exploited as a photosensitizer, whereby red light irradiation of the diseased tissue that has been treated with 5-ALA produces a localized burst of cytotoxic reactive oxygen species. 8, 9 In the oncology clinic, 5-ALA is administered either topically or systemically, and in both cases only a small fraction of the dose enters cells, primarily via endogenous amino acid transporters. After systemic treatment, the patient remains photosensitive until all of the 5-ALA is cleared from the body, which can take up two days. 4, 10 In principle, this clinical drawback could be ameliorated if the 5-ALA was delivered selectively to tumors. Recent research efforts have explored covalent modification 11, 12 or colloidal encapsulation 8, 13, 14 as new methods to enhance cellular uptake of 5-ALA after topical administration. But to the best of our knowledge, there are no reported studies of living subjects treated systemically with nanoparticles containing 5-ALA. This is somewhat surprising since stealth liposomes are well-known as drug delivery vehicles that accumulate within solid tumors due to the enhanced permeation retention (EPR) effect. However, the classic dilemma with stealth liposomes is that the polyethylene glycol † Abbreviations:1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (PEG) corona that surrounds the stealth liposomes and ensures avoidance of the reticuloendothelial system, also makes it hard for drugs to leak from the liposomes. Thus, the technical challenge with stealth liposomes is to induce drug release after the liposomes have reached the tumor tissue. 15 Various methods have been investigated to trigger liposome leakage including changes in temperature, pH, light, ultrasound, and covalent bond cleavage. [16] [17] [18] Our lab is interested in developing an alternative release strategy using a non-covalent chemical trigger. 19 The general concept is envisioned as a two-step dosing procedure that first administers drugfilled stealth liposomes, followed by a waiting period for tumor accumulation, and then a dose of non-toxic chemical trigger to rapidly release the drug from the liposomes at the tumor (Scheme 1). 20 An attractive feature with this strategy is that knowledge of the tumor location(s) is not a Figure 2 ). 19 The small fraction of DPPE-PEG 2000 provides the liposomes with steric protection 24 and together with the POPS gives the liposome surface a net anionic charge. Mechanistic studies indicate that selective association of cationic chemical trigger 1 with the anionic PS embedded in the liposome membrane causes lateral phase separation of ordered and disordered phases. [25] [26] [27] This leads to mismatched membrane thicknesses at the phase interface and defects that allow leakage of aqueous contents. 28 Here, we advance this controlled release concept by reporting the discovery of a next-generation chemical trigger that operates much more effectively than the old trigger 1 in physiological conditions.
Using this new chemical trigger, we demonstrate greatly enhanced release of 5-ALA prodrug from liposomes in the presence of healthy mammalian cells, followed by cell entry of the 5-ALA and subsequent biosynthesis into photoactive PpIX (Scheme 1).
Results and Discussion

Chemical Synthesis
The structures of chemical triggers 2, 3, 4, and 5 are provided in Figure 2 and the synthetic pathways are shown in Figure 3 . Chemical triggers 2 and 3 were prepared by treating compound apo-1 with the appropriate bis(succinate ester) to give apo-2 and apo-3, followed by complexation with Zn(NO 3 ) 2 in MeOH. Compound 6 was prepared according to literature precedent and was treated with butylisocyanate to prepare 7 in modest yield. 21 Treatment of 7
with hydrazine monohydrate effectively removed the phthalimide protecting group and produced primary amine apo-4 that was complexed with Zn(NO 3 ) 2 to yield chemical trigger 4 ( Figure 2 ). with covalent linkers of different lengths ( Figure 2 ). But these dimeric structures only produced marginally better CF leakage in PBS of 49 % compared to the 34 % seen with 1 (compare entry 1 with entries 4 and 6, Table 1 ). We also tested ZnBDPA complexes 4 and 5, which are modified structures with a ureido group covalently attached to each of the BDPA units ( Figure 2 ). We recently showed that ureido modified ZnBDPA structures have selective and enhanced affinity for PS-rich membranes and furthermore they are able to permeate through the membranes. 21 Thus, we expected structures 4 and 5 to perform well as selective chemical triggers of leakage from PS-rich liposomes. A modest CF leakage enhancement in PBS was seen with modified
ZnBDPA structure 4 (43 %, entry 8, Table 1 ), but we were pleased to observe a much larger amount of leakage (71 %, entry 10, Table 1 Table 1 ) but still significant leakage induced by 5 (36 %, entry 12, Table 1 ).
The next step was to confirm that next-generation chemical trigger 5 was able to release 5-ALA from stealth liposomes. Liposomes encapsulating 5-ALA were prepared by the thin film hydration method. Note that a very small amount of fluorescent DiIC 18 , a lipophilic membrane tracer, was added to the liposome composition to facilitate purification and characterization of the final liposomal solution. The concentration of 5-ALA was measured using a simple colorimetric assay reported by Tomokuni and Ogata with only minor modification. 31 Final preparations of liposomes encapsulating 5-ALA were typically composed of 2.7 mM total lipid and 5.1 mM 5-ALA; these results correspond to 2 % encapsulation efficiency (which is consistent with literature precedent) and 30 % liposome loading by weight. The average liposome size was measured to be 200 ± 3 nm using dynamic light scattering and was unchanged after storage at room temperature for several days ( Figure S1 ). To measure release of 5-ALA a dialysis assay was developed using a dialysis device with source and receiver compartments that were separated by a porous membrane with 8,000 molecular weight cutoff. Initially, liposomes filled with 5-ALA were added to the source compartment and the amount of 5-ALA in both the source and receiver compartments were measured over time. In the absence of chemical trigger the liposomes remained intact in the source compartment, releasing <10 % of the encapsulated 5-ALA ( Figure S2 ). Exposure to Triton-X-100 led to liposome lysis and complete equilibration of the released 5-ALA between source and receiver compartments (100 % release) within 24 hours.
In comparison, treatment of the liposomal 5-ALA with chemical trigger 5 led to 80 % release of the encapsulated 5-ALA after 24 hours.
Cell Uptake Studies
The next goal was to demonstrate that ZnBDPA complex 5 could trigger 5-ALA release from liposomes in the presence of healthy mammalian cells, with subsequent permeation of the released 5-ALA into the cells, followed by intracellular biosynthesis into red fluorescent PpIX.
For experimental convenience we conducted these experiments using CHO-K1 (chinese hamster ovary) cells which are easy to cultivate and known to have moderate intracellular PpIX biosynthesis activity. 32 An MTT cell viability assay of these cells showed that there was negligible cytotoxicity (greater than 80 % cell viability) when the concentration of trigger 5 was kept under 100 µM ( Figure S3 ). The amount of biosynthesized PpIX was determined using a standard fluorescence assay that measured the increase in red PpIX fluorescence produced by the cell culture. The bar graph in Figure 5 shows the amount of PpIX produced at six hours after various treatments. In each case, the concentration of 5-ALA added to the cell culture well was 100 µM. Cell treatment with free 5-ALA increased the relative concentration of PpIX by a factor of three, whereas cell treatment with liposomal 5-ALA hardly changed the relative concentration of PpIX, which was expected since the encapsulated 5-ALA is prevented from entering the cells.
In contrast, a sequential treatment of cells with liposomal 5-ALA followed by chemical trigger 5 (6.6 µM) led to the expected three-fold increase in PpIX production.
A visual demonstration of the trigger release effect is shown in Figure 6 solutions were allowed to shake for 1 hour before solvent was removed by rotary evaporation.
Residual solvent was removed under vacuum over a period of at least 1 hour.
Liposome Preparation
All phospholipids were purchased from Avanti Polar Lipids (Alabaster, AL) and stored at -20 °C until use. Liposomes were prepared using the thin film hydration method, followed by membrane extrusion for size control. Appropriately sized aliquots of lipid solutions were added to a clean, dry test tube. Solvent was removed by evaporation using a gentle stream of N 2 gas.
Residual solvent was removed under vacuum over a period of at least 1 hour. Lipids were rehydrated with the desired buffer. A glass ring was added to the solution to ensure complete removal of all lipid from the test tube wall and the solution was vortexed. The suspension was extruded 21 times through a 19 mm polycarbonate membrane with 200 nm diameter pores.
Liposomes were used on the day of preparation.
Carboxyfluorescein Release from Liposomes
Liposomes were prepared using the thin film hydration method upon hydration with TES buffer (5 mM TES, 145 mM NaCl, pH 7.4) containing carboxyfluorescein (CF, 50 mM). Figure S1 ). Dialysis experiments show <10 % leakage over 24 hours and the liposomes appear to be stable for days at room temperature.
Preparation of Modified Ehrlich's Reagent
To a solution of 30 mL glacial acetic acid was added p-dimethylaminobenzaldehyde (1.0 g, 6.7 mmol), 60 % perchloric acid (5 mL), and distilled water (5 mL). The solution was mixed and diluted to a final volume of 50 mL using glacial acetic acid.
Dialysis Experiments
Release of Brightfield images were captured and corresponding fluorescence images were normalized to the highest intensity (60 x magnification, 46 ms exposure time).
MTT Cell Viability Assay
Cell viability was measured using the 3- ( 
Statistical Analysis
Results are depicted as mean ± standard error of the mean (SEM). Statistical analysis was performed using a Student's t test. 
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